CIK 0001819576
- Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851710962
- Phone
- +1 919-328-4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,616,882
- in 14 filings, $3.0M under 10b5-1 plans
Net −$10,616,882. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-30 | Kaseta Michael CFO and COO | Exercise or conversion · Restricted Stock Unit 10b5-1 | −2,344 | 14,062 | ||
| 2024-08-30 | Adair Jason Chief Business Officer | Exercise or conversion 10b5-1 | +1,562 | 116,269 | ||
| 2024-08-30 | Adair Jason Chief Business Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,562 | 9,375 | ||
| 2024-08-30 | Caligan Partners LP Director | Other disposition | −3,440,948 | 6,994,997 | ||
| 2024-08-30 | Caligan Partners LP Director | Sale | −150,000 | $9.51 | $1.4M | 6,844,997 |
| 2024-08-30 | Caligan Partners LP Director | Purchase | +150,000 | $9.51 | $1.4M | 6,994,997 |
| 2024-07-26 | Adair Jason Chief Business Officer | Sale 10b5-1 | −1,833 | $11.44 | $21K | 113,393 |
| 2024-07-19 | Saggar Rajeev Chief Medical Officer | Sale 10b5-1 | −1,873 | $11.13 | $21K | 208,329 |
| 2024-07-12 | JEFFS ROGER Chief Executive Officer | Sale 10b5-1 | −8,053 | $12.53 | $101K | 818,932 |
| 2024-07-12 | Moomaw Scott Chief Commercial Officer | Sale 10b5-1 | −1,528 | $12.53 | $19K | 151,682 |
| 2024-07-12 | Adair Jason Chief Business Officer | Sale 10b5-1 | −1,146 | $12.53 | $14K | 115,226 |
| 2024-07-12 | Schundler Russell General Counsel | Sale 10b5-1 | −1,985 | $12.53 | $25K | 485,676 |
| 2024-07-12 | Saggar Rajeev Chief Medical Officer | Sale 10b5-1 | −1,470 | $12.53 | $18K | 210,202 |
| 2024-07-12 | Kaseta Michael CFO and COO | Sale 10b5-1 | −3,906 | $12.53 | $49K | 312,389 |
| 2024-07-11 | Adair Jason Chief Business Officer | Exercise or conversion 10b5-1 | +3,907 | 116,372 | ||
| 2024-07-11 | Adair Jason Chief Business Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −3,907 | 39,062 | ||
| 2024-06-20 | SINGH RAMAN Director | Grant or award | +20,359 | 20,359 | ||
| 2024-06-20 | Rielly-Gauvin Katherine Director | Grant or award | +20,359 | 20,359 | ||
| 2024-06-20 | Manning Paul B Director | Grant or award | +20,359 | 299,689 | ||
| 2024-06-20 | Kirsch Arthur S Director | Grant or award | +20,359 | 22,359 |
Page 31 of 39 · 771 trades